Congratulations to the 2017 PM&R Journal Best Paper Award Recipients
CMS Finalizes Policies that Reduce Provider Burden, Lower Drug Prices
Experts Needed for Instructional Videos
Fresenius Kabi Issues Voluntary Nationwide Recall of Midazolam Injection, USP, 2 mg/2 mL Due to Reports of Blister Packages Containing Syringes of Ondansetron Injection, USP, 4 mg/2 mL
Physio-Control Launches Voluntary Field Action for Specific Production Lots of Infant/Child Reduced Energy Defibrillation Electrodes Produced by Cardinal Health
Ridge Properties DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of all lots of Naturally HL Bedsore Cream, Pretat by TAT Balm Carbomer Free Gel, & All Naturally HL Hemorrhoid products due to manufacturing concerns at the facility
CMS Finalizes Quality Payment Program Rule for Year 2 to Increase Flexibility and Reduce Burdens
Renew Your 2018 AAPM&R Membership
2018 Call for Proposals and Abstracts is Open
Dr. Andrew Friedman Appointed to NQP Opioid Stewardship Action Team
National Quality Forum (NQF) Seeking Patients to Serve on Cancer Standing Committee
Physician Compare 30-Day Preview Period Extended to 12/1
Commit to Help Reduce Firearm-Related Violence
Choosing Wisely® Campaign Marks Fifth Anniversary
AAPM&R Members in the News: October 2017
AAPM&R Submits Comments to AMA on Burdensome Certification and LCD Requirements
AAPM&R Submits Comments on CMS Proposed Rule: Cancellation of Advancing Care Coordination
Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal
Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination
URGENT – Voluntary Market Withdrawal – October 13, 2017: octagam [Immune Globulin Intravenous (human)] 10% Liquid Preparation]